Allergic Rhinitis Treatment Market

Allergic rhinitis is commonly known as Hay fever, caused by some of the typical allergens namely pollen, grass, dust, animal dander, cat saliva and mold. Apart from this common allergens, some of the other major factors responsible for the disease are cigarette smoke, chemicals, cold temperatures, humidity, wind, air pollution, hairspray, perfumes & colognes, wood smoke, and fumes. This is the most common allergic disease found in majority of the countries with a prevalence range of between 2 to 40% in various countries across the globe.  Allergic rhinitis refers to a chronic inflammatory disease affecting the nasal cavity identified by some of the common symptoms such as Nasal itching, sore throat, runny or blocked nose, and sneezing are some of the characteristic symptoms of allergic rhinitis.

Globally demand for allergic rhinitis treatment market is driven by factors such as increasing awareness amongst people about disease and increasing number of respiratory problems related cases due to increasing pollution and tobacco consumption.

This report identifies the allergic rhinitis treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to allergic rhinitis treatment market.

Allergic Rhinitis Treatment Market

Globally demand for allergic rhinitis treatment is expected to witness growth in the upcoming future due to increasing respiratory disease globally. North America represents the highest market share in the global allergic rhinitis treatment market as reported cases for allergic rhinitis is highest in the U.S. followed by Europe with the second highest market share amongst all the major regions.
  • This report on allergic rhinitis treatment has been divided based on disease type, which is segmented as: Perennial allergic rhinitis and Seasonal allergic rhinitis
  • Allergic rhinitis treatment market is further also segmented based on the available treatments which includes major treatment namely: Antihistamines, Intranasal corticosteroids, Immunotherapies, Decongestants and others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the Allergic Rhinitis market. Some of the major companies’ profiles in detail are as follows:
  • GlaxoSmithKline
  • Sanofi
  • AstraZeneca
  • Meda Pharmaceuticals
  • Dr Reddy's Laboratories


Request Sample Data